Zoetis 

$79.77
1951
+$0.20+0.25% 今天

統計

當日最高
82.05
當日最低
78.92
52週高點
168.82
52週低點
74.22
成交量
2,392,485,157
平均成交量
-
市值
33.67B
本益比
13.04
股息殖利率
2.66%
股息
2.13

即將到來

股息

2.66%股息殖利率
Jun 26
$0.53
Mar 26
$0.53
Dec 25
$0.50
Sep 25
$0.50
Jun 25
$0.50
10年成長
18.76%
5年成長
16.22%
3年成長
12.22%
1年成長
6%

財報

11Aug預期
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
下一步
1.36
1.53
1.69
1.86
預期EPS
1.857798
實際EPS
不適用

財務

28.23%利潤率
有盈利
2020
2021
2022
2023
2024
2025
18.93B營收
5.35B淨利

分析師評級

118.50平均目標價
最高預估為 140.00。
來自過去6個月內的 7 則評分。這不是投資建議。
買入
29%
持有
71%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 ZTS 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its comprehensive portfolio serves a broad spectrum of species, encompassing both livestock, including cattle, swine, poultry, fish, and sheep, and beloved companion animals such as dogs, cats, and horses. Among its pharmaceutical offerings are various therapeutic agents. This includes vaccines, vital for preventing respiratory, gastrointestinal, and reproductive diseases by stimulating a targeted immune response; anti-infectives that combat or inhibit the proliferation of bacterial, fungal, or protozoal pathogens; and parasiticides aimed at eradicating both internal and external pests such as fleas, ticks, and various worms. Additional pharmaceuticals address areas such as pain management and sedation, anti-emesis, reproductive health, and oncology. The portfolio also features dermatological solutions for allergic skin conditions and atopic dermatitis, alongside medicated feed additives specifically designed for livestock. Beyond therapeutics, Zoetis offers an extensive array of diagnostic solutions. These include portable analysis systems for blood and urine, point-of-care testing devices, specialized instruments and reagents, rapid immunoassay kits, comprehensive reference laboratory services, and blood glucose monitoring equipment. Further extending its reach, the company provides supplementary offerings such as nutritional products, agribusiness support services, biodevices, genetic testing, and innovations in precision animal health. Zoetis distributes its diverse product portfolio to a broad customer base, including veterinary professionals, livestock producers, and retail channels. This distribution occurs directly via its sales representatives and technical specialists, as well as through partnerships with third-party veterinary distributors. Established in 1952, the company maintains its corporate headquarters in Parsippany, New Jersey.
Show more...
執行長
Ms. Kristin C. Peck
員工
13800
國家
美國
ISIN
US98978V1035

上市

1 Comments

分享你的想法

FAQ

Zoetis 今天的股價是多少?
ZTS 目前價格為 $79.77 USD,過去 24 小時上漲了 +0.25%。在圖表上更密切關注 Zoetis 股價表現。
Zoetis 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Zoetis 的股票以代號 ZTS 進行交易。
Zoetis 的股價在上漲嗎?
ZTS 股票較上週上漲 +1.22%,本月上漲 +7.49%,但過去一年 Zoetis 下跌 -51.45%。
Zoetis 的市值是多少?
今天 Zoetis 的市值為 33.67B
Zoetis 下一次財報日期是什麼時候?
Zoetis 將於 August 11, 2026 公布下一次財報。
Zoetis 上一季度的財報如何?
ZTS 上一季度的財報為每股 1.53 USD,預估為 1.6 USD,帶來 -4.6% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Zoetis 去年的營收是多少?
Zoetis 去年的營收為 18.93BUSD。
Zoetis 去年的淨利是多少?
ZTS 去年的淨收益為 5.35BUSD。
Zoetis 會發放股息嗎?
是的,ZTS 的股息每 每季 發放一次。每股最新股息為 0.53 USD。截至今日,股息殖利率(FWD)% 為 2.66%。
Zoetis 有多少名員工?
截至 June 15, 2026,公司共有 13,800 名員工。
Zoetis 位於哪個產業?
Zoetis從事於Health & Wellness產業。
Zoetis 何時完成拆股?
Zoetis 最近沒有進行任何拆股。
Zoetis 的總部在哪裡?
Zoetis 的總部位於 美國 的 Parsippany。